2021
DOI: 10.1021/acs.jmedchem.1c01241
|View full text |Cite
|
Sign up to set email alerts
|

Pillar[5]arene-Based Polycationic Glyco[2]rotaxanes Designed as Pseudomonas aeruginosa Antibiofilm Agents

Abstract: Pseudomonas aeruginosa is a human pathogen belonging to the top priorities for the discovery of new therapeutic solutions. Its propensity to generate biofilms strongly complicates the treatments required to cure P. aeruginosa infections. Herein we describe the synthesis of a series of novel rotaxanes comprised of a central galactosylated pillar [5]arene, a tetrafucosylated dendron and a tetra-guanidinium subunit. Strategically, we exploited a supramolecular assembly technology to generate complex rotaxanes fro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 61 publications
0
14
0
Order By: Relevance
“…To generate a potent biofilm inhibitor targeting the P. aeruginosa lectins LecA and LecB, Mohy El Dine et al chose a supramolecular scaffold, and combined a cationic unit that showed promising anti-biofilm properties, but lacked selectivity for the target lectin, with heteroglycoclusters to selectively target LecA and LecB (Figure 2C). [22] The heterovalent glyco[2]rotaxanes 10 a-c were generated by supramolecular assembly of the central pillar[5]arene 7 deca-galactosylated with 9 to address LecA, the tetrafucosylated dendron 6 to target LecB, and the polyguanidinium tail 8 as cationic unit to prevent biofilm formation. Binding assays were performed, and valency-corrected RIP values were obtained, which were related to the references β-d-GalOMe (LecA) and α-l-FucOMe (LecB) (Table 2).…”
Section: Glycan-based Antibacterial Inhibitors 21 Heteromultivalent S...mentioning
confidence: 99%
“…To generate a potent biofilm inhibitor targeting the P. aeruginosa lectins LecA and LecB, Mohy El Dine et al chose a supramolecular scaffold, and combined a cationic unit that showed promising anti-biofilm properties, but lacked selectivity for the target lectin, with heteroglycoclusters to selectively target LecA and LecB (Figure 2C). [22] The heterovalent glyco[2]rotaxanes 10 a-c were generated by supramolecular assembly of the central pillar[5]arene 7 deca-galactosylated with 9 to address LecA, the tetrafucosylated dendron 6 to target LecB, and the polyguanidinium tail 8 as cationic unit to prevent biofilm formation. Binding assays were performed, and valency-corrected RIP values were obtained, which were related to the references β-d-GalOMe (LecA) and α-l-FucOMe (LecB) (Table 2).…”
Section: Glycan-based Antibacterial Inhibitors 21 Heteromultivalent S...mentioning
confidence: 99%
“…112 Such advanced copillararenes are now being assayed for diverse biological applications including bacterial biofilm eradication. 123 They are also being studied for applications in antivirulence, [124][125][126] as antibiofilm agents and for multivalent enzyme inhibition.…”
Section: Further Functionalizations Of Heteroglycoclustersmentioning
confidence: 99%
“…This comprehensive overview will be of value to a broad audience of synthetic and medicinal chemists in academia and in industry, aiming to build new therapeutic or diagnostic tools against PA. This topic is timely, and indeed some inspiring examples have been published in the last two years illustrating novel complementary therapeutic approaches, including targeted biofilm inhibition activity, [11] directing antibiotics to the bacteria by lectintargeting, [12] and hijacking the ability of the bacterium to utilise glycocluster-conjugated siderophores for iron-transport as a 'Trojan horse' strategy. [13] 1.1.…”
Section: Introductionmentioning
confidence: 99%